Register und Studien des Deutschen Kompetenznetzes Vorhofflimmern (AFNET)
Standard
Register und Studien des Deutschen Kompetenznetzes Vorhofflimmern (AFNET). / Nabauer, M; Gerth, A; Kirchhof, P; Goette, A; Limbourg, T; Sprenger, C; Hoffmann, B; Willems, S; Doll, N; Schuchert, A; Oeff, M; Ravens, U; Meinertz, T; Steinbeck, G; Breithardt, G.
In: Herzschrittmacherther Elektrophysiol, Vol. 21, No. 3, 09.2010, p. 153-159.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Register und Studien des Deutschen Kompetenznetzes Vorhofflimmern (AFNET)
AU - Nabauer, M
AU - Gerth, A
AU - Kirchhof, P
AU - Goette, A
AU - Limbourg, T
AU - Sprenger, C
AU - Hoffmann, B
AU - Willems, S
AU - Doll, N
AU - Schuchert, A
AU - Oeff, M
AU - Ravens, U
AU - Meinertz, T
AU - Steinbeck, G
AU - Breithardt, G
PY - 2010/9
Y1 - 2010/9
N2 - The German Competence Network on Atrial Fibrillation (AFNET) is a national interdisciplinary research network funded by the Federal Ministry of Education and Research (BMBF). AFNET was initiated in 2003 and aims at improving treatment of atrial fibrillation (AF), the most frequent sustained cardiac arrhythmia. AFNET has established a nationwide patient registry on diagnostics, therapy, course and complications of AF in Germany. The data analyzed to date demonstrate that patients with AF are likely to have multiple co-morbidities, such as hypertension, valvular heart disease, coronary artery disease, diabetes mellitus and advanced age. Oral anticoagulation is provided to the majority of patients in accordance with the recommendations given by guidelines. Further areas of research deal with the optimal duration of antiarrhythmic therapy following electrical cardioversion of atrial fibrillation and the value of strategies to prevent arrhythmogenic changes, such as fibrosis in the atria, for prevention of further episodes of atrial fibrillation. Additional registry projects were established for patients with catheter-based interventional therapy of atrial fibrillation and surgical ablation to define success, complications and long term results of these recently developed procedures more clearly. Data and insights gathered from these projects were used to further develop standards of care in two international conferences.
AB - The German Competence Network on Atrial Fibrillation (AFNET) is a national interdisciplinary research network funded by the Federal Ministry of Education and Research (BMBF). AFNET was initiated in 2003 and aims at improving treatment of atrial fibrillation (AF), the most frequent sustained cardiac arrhythmia. AFNET has established a nationwide patient registry on diagnostics, therapy, course and complications of AF in Germany. The data analyzed to date demonstrate that patients with AF are likely to have multiple co-morbidities, such as hypertension, valvular heart disease, coronary artery disease, diabetes mellitus and advanced age. Oral anticoagulation is provided to the majority of patients in accordance with the recommendations given by guidelines. Further areas of research deal with the optimal duration of antiarrhythmic therapy following electrical cardioversion of atrial fibrillation and the value of strategies to prevent arrhythmogenic changes, such as fibrosis in the atria, for prevention of further episodes of atrial fibrillation. Additional registry projects were established for patients with catheter-based interventional therapy of atrial fibrillation and surgical ablation to define success, complications and long term results of these recently developed procedures more clearly. Data and insights gathered from these projects were used to further develop standards of care in two international conferences.
KW - Aged
KW - Anti-Arrhythmia Agents/therapeutic use
KW - Anticoagulants/therapeutic use
KW - Atrial Fibrillation/complications
KW - Biomedical Research
KW - Cardiovascular Diseases/complications
KW - Catheter Ablation
KW - Combined Modality Therapy
KW - Comorbidity
KW - Cooperative Behavior
KW - Electric Countershock
KW - Evidence-Based Medicine
KW - Female
KW - Germany
KW - Humans
KW - Interdisciplinary Communication
KW - Male
KW - Outcome and Process Assessment, Health Care
KW - Practice Guidelines as Topic
KW - Quality Assurance, Health Care/organization & administration
KW - Randomized Controlled Trials as Topic
KW - Registries
U2 - 10.1007/s00399-010-0097-7
DO - 10.1007/s00399-010-0097-7
M3 - SCORING: Zeitschriftenaufsatz
C2 - 20676664
VL - 21
SP - 153
EP - 159
JO - Herzschrittmacherther Elektrophysiol
JF - Herzschrittmacherther Elektrophysiol
SN - 1435-1544
IS - 3
ER -
